Lorazepam and Skin hypertrophy - a phase IV clinical study of FDA data

Summary:

Skin hypertrophy is reported as a side effect among people who take Lorazepam (lorazepam), especially for people who are female, 60+ old, also take Magnevist, and have Nuclear magnetic resonance imaging brain.

The phase IV clinical study analyzes which people have Skin hypertrophy when taking Lorazepam. It is created by eHealthMe based on reports of 161,687 people who have side effects when taking Lorazepam from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Skin hypertrophy?

Skin hypertrophy (skin cells enlarges) is found to be associated with 588 drugs and 547 conditions by eHealthMe. Check the latest studies of Skin hypertrophy.

On Aug, 06, 2026

161,687 people reported to have side effects when taking Lorazepam.
Among them, 28 people (0.02%) have Skin hypertrophy.

Among these 28 people:

What is the gender of people who have Skin hypertrophy when taking Lorazepam? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Skin hypertrophy when taking Lorazepam? *

What are other drugs people take besides Lorazepam? *

What are other side effects people have besides Skin hypertrophy? *

Pain: 21 people, 75.00%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 20 people, 71.43%
Skin Discoloration: 15 people, 53.57%
Skin Induration (an abnormally hard spot or area on the skin): 15 people, 53.57%
Skin Tightness: 14 people, 50.00%
Itching: 14 people, 50.00%
Rashes (redness): 14 people, 50.00%
Oedema Peripheral (superficial swelling): 14 people, 50.00%
Mobility Decreased (ability to move is reduced): 14 people, 50.00%
Joint Range Of Motion Decreased (disease of joint movement): 13 people, 46.43%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 6 people, 21.43%
Pain: 5 people, 17.86%
Nuclear Magnetic Resonance Imaging Abdominal: 4 people, 14.29%
Pain In Extremity: 3 people, 10.71%
Wound Complication: 2 people, 7.14%
Itching: 2 people, 7.14%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 7.14%
Gastric Disorder (disease of stomach): 2 people, 7.14%
Neuralgia (pain in one or more nerves): 2 people, 7.14%
Cough: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and have Skin hypertrophy?

- Check whether Skin hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lorazepam:

Lorazepam (165,639 reports)

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin hypertrophy:

Skin hypertrophy (588 drugs)

Browse all the conditions that are associated with Skin hypertrophy:

Skin hypertrophy (547 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Lorazepam) and Lorazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.